Background: Recent data provide support for the concept that potentially modifiable exposures are responsible for sporadic amyotrophic lateral sclerosis (ALS). Objective: To evaluate environmental and occupational exposures as risk factors for sporadic ALS. Methods: We performed a case-control study of ALS among residents of New England, USA. The analysis compared questionnaire responses from 295 patients with a confirmed ALS diagnosis to those of 225 controls without neurodegenerative illness. Results: Self-reported job- or hobby-related exposure to one or more chemicals, such as pesticides, solvents, or heavy metals, increased the risk of ALS (adjusted OR 2.51; 95% CI 1.64-3.89). Industries with a higher toxicant exposure potential (construction, manufacturing, mechanical, military, or painting) were associated with an elevated occupational risk (adjusted OR 3.95; 95% CI 2.04-8.30). We also identified increases in the risk of ALS associated with frequent participation in water sports, particularly waterskiing (adjusted OR 3.89; 95% CI 1.97-8.44). Occupation and waterskiing both retained independent statistical significance in a composite model containing age, gender, and smoking status. Conclusions: Our study contributes to a growing body of literature implicating occupational- and hobby-related toxicant exposures in ALS etiology. These epidemiologic study results also provide motivation for future evaluation of water-body-related risk factors.

1.
Chio A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, White LA: Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 2013;41:118-130.
2.
Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, Heverin M, Howard RS, Huisman MH, Keren N, Leigh PN, Mazzini L, Mora G, Orrell RW, Rooney J, Scott KM, Scotton WJ, Seelen M, Shaw CE, Sidle KS, Swingler R, Tsuda M, Veldink JH, Visser AE, van den Berg LH, Pearce N: Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol 2014;13:1108-1113.
3.
Sutedja NA, Fischer K, Veldink JH, Van Der Heijden GJ, Kromhout H, Heederik D, Huisman MH, Wokke JJ, Van Den Berg LH: What we truly know about occupation as a risk factor for ALS: a critical and systematic review. Amyotroph Lateral Scler 2009;10:295-301.
4.
Malek AM, Barchowsky A, Bowser R, Heiman-Patterson T, Lacomis D, Rana S, Youk A, Stickler D, Lackland DT, Talbott EO: Environmental and occupational risk factors for amyotrophic lateral sclerosis: a case-control study. Neurodegener Dis 2014;14:31-38.
5.
Beard JD, Kamel F: Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival. Epidemiol Rev 2015;37:55-70.
6.
Weisskopf MG, Cudkowicz ME, Johnson N: Military service and amyotrophic lateral sclerosis in a population-based cohort. Epidemiology 2015;26:831-838.
7.
Fang F, Quinlan P, Ye W, Barber MK, Umbach DM, Sandler DP, Kamel F: Workplace exposures and the risk of amyotrophic lateral sclerosis. Environ Health Perspect 2009;117:1387-1392.
8.
Schmidt S, Kwee LC, Allen KD, Oddone EZ: Association of ALS with head injury, cigarette smoking and APOE genotypes. J Neurol Sci 2010;291:22-29.
9.
Abhinav K, Al-Chalabi A, Hortobagyi T, Leigh PN: Electrical injury and amyotrophic lateral sclerosis: a systematic review of the literature. J Neurol Neurosurg Psychiatry 2007;78:450-453.
10.
Pupillo E, Messina P, Logroscino G, Zoccolella S, Chio A, Calvo A, Corbo M, Lunetta C, Micheli A, Millul A, Vitelli E, Beghi E; EURALS Consortium: Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry. Eur J Neurol 2012;19:1509-1517.
11.
Malek AM, Barchowsky A, Bowser R, Heiman-Patterson T, Lacomis D, Rana S, Ada Y, Talbott EO: Exposure to hazardous air pollutants and the risk of amyotrophic lateral sclerosis. Environ Pollut 2015;197:181-186.
12.
Belbasis L, Bellou V, Evangelou E: Environmental risk factors and amyotrophic lateral sclerosis: an umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of observational studies. Neuroepidemiology 2016;46:96-105.
13.
Johnson FO, Atchison WD: The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis. Neurotoxicology 2009;30:761-765.
14.
McGuire V, Longstreth WT Jr, Nelson LM, Koepsell TD, Checkoway H, Morgan MS, van Belle G: Occupational exposures and amyotrophic lateral sclerosis: a population-based case-control study. Am J Epidemiol 1997;145:1076-1088.
15.
Banack SA, Caller TA, Stommel EW: The cyanobacteria derived toxin beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis. Toxins (Basel) 2010;2:2837-2850.
16.
Costa J, Swash M, de Carvalho M: Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: a systematic review. Arch Neurol 2012;69:1410-1416.
17.
Heck JE, Andrew AS, Onega T, Rigas JR, Jackson BP, Karagas MR, Duell EJ: Lung cancer in a US population with low to moderate arsenic exposure. Environ Health Perspect 2009;117:1718-1723.
18.
Kamel F, Umbach DM, Munsat TL, Shefner JM, Hu H, Sandler DP: Lead exposure and amyotrophic lateral sclerosis. Epidemiology 2002;13:311-319.
19.
Fang F, Kwee LC, Allen KD, Umbach DM, Ye W, Watson M, Keller J, Oddone EZ, Sandler DP, Schmidt S, Kamel F: Association between blood lead and the risk of amyotrophic lateral sclerosis. Am J Epidemiol 2010;171:1126-1133.
20.
Gunnarsson LG, Lindberg G, Soderfeldt B, Axelson O: Amyotrophic lateral sclerosis in Sweden in relation to occupation. Acta Neurol Scand 1991;83:394-398.
21.
Bonvicini F, Marcello N, Mandrioli J, Pietrini V, Vinceti M: Exposure to pesticides and risk of amyotrophic lateral sclerosis: a population-based case-control study. Ann Ist Super Sanita 2010;46:284-287.
22.
Su FC, Goutman SA, Chernyak S, Mukherjee B, Callaghan BC, Batterman S, Feldman EL: Association of environmental toxins with amyotrophic lateral sclerosis. JAMA Neurol 2016;73:803-811.
23.
Burns CJ, Beard KK, Cartmill JB: Mortality in chemical workers potentially exposed to 2,4-dichlorophenoxyacetic acid (2,4-D) 1945-94: an update. Occup Environ Med 2001;58:24-30.
24.
McGuire V, Longstreth WT Jr, Nelson LM, Koepsell TD, Checkoway H, Morgan MS, van Belle G: Occupational exposures and amyotrophic lateral sclerosis: a population-based case-control study. Am J Epidemiol 1997;145:1076-1088.
25.
Fang F, Quinlan P, Ye W, Barber MK, Umbach DM, Sandler DP, Kamel F: Workplace exposures and the risk of amyotrophic lateral sclerosis. Environ Health Perspect 2009;117:1387-1392.
26.
Weisskopf MG, McCullough ML, Morozova N, Calle EE, Thun MJ, Ascherio A: Prospective study of occupation and amyotrophic lateral sclerosis mortality. Am J Epidemiol 2005;162:1146-1152.
27.
Stommel EW, Field NC, Caller TA: Aerosolization of cyanobacteria as a risk factor for amyotrophic lateral sclerosis. Med Hypotheses 2013;80:142-145.
28.
Stewart I, Webb PM, Schluter PJ, Shaw GR: Recreational and occupational field exposure to freshwater cyanobacteria - a review of anecdotal and case reports, epidemiological studies and the challenges for epidemiologic assessment. Environ Health 2006;5:6.
29.
Cox PA, Davis DA, Mash DC, Metcalf JS, Banack SA: Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain. Proc Biol Sci 2016;283:20152397.
30.
Centers for Disease Control and Prevention: BRFSS prevalence and trends data. http://www.dev.cdc.gov/brfss/brfssprevalence/.
31.
Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, Heverin M, Howard RS, Huisman MH, Keren N, Leigh PN, Mazzini L, Mora G, Orrell RW, Rooney J, Scott KM, Scotton WJ, Seelen M, Shaw CE, Sidle KS, Swingler R, Tsuda M, Veldink JH, Visser AE, van den Berg LH, Pearce N: Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol 2014;13:1108-1113.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.